vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and CB Financial Services, Inc. (CBFV). Click either name above to swap in a different company.

BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $13.8M, roughly 1.4× CB Financial Services, Inc.). On growth, BIOLIFE SOLUTIONS INC posted the faster year-over-year revenue change (24.3% vs 19.9%). Over the past eight quarters, CB Financial Services, Inc.'s revenue compounded faster (1.2% CAGR vs 1.0%).

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

BLFS vs CBFV — Head-to-Head

Bigger by revenue
BLFS
BLFS
1.4× larger
BLFS
$18.8M
$13.8M
CBFV
Growing faster (revenue YoY)
BLFS
BLFS
+4.5% gap
BLFS
24.3%
19.9%
CBFV
Faster 2-yr revenue CAGR
CBFV
CBFV
Annualised
CBFV
1.2%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLFS
BLFS
CBFV
CBFV
Revenue
$18.8M
$13.8M
Net Profit
$11.1M
Gross Margin
Operating Margin
7.2%
38.1%
Net Margin
58.9%
Revenue YoY
24.3%
19.9%
Net Profit YoY
-11.1%
EPS (diluted)
$0.23
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
CBFV
CBFV
Q4 25
$18.8M
$13.8M
Q3 25
$28.1M
$2.4M
Q2 25
$25.4M
$13.5M
Q1 25
$23.9M
$12.1M
Q4 24
$15.1M
$13.2M
Q3 24
$21.4M
$12.7M
Q2 24
$19.7M
$12.2M
Q1 24
$18.4M
$13.5M
Net Profit
BLFS
BLFS
CBFV
CBFV
Q4 25
$11.1M
Q3 25
$621.0K
$-5.7M
Q2 25
$-15.8M
$3.9M
Q1 25
$-448.0K
$1.9M
Q4 24
$12.5M
Q3 24
$-1.7M
$3.2M
Q2 24
$-20.7M
$2.6M
Q1 24
$-10.2M
$4.2M
Operating Margin
BLFS
BLFS
CBFV
CBFV
Q4 25
7.2%
38.1%
Q3 25
-0.3%
-289.8%
Q2 25
-65.5%
35.0%
Q1 25
-5.1%
19.3%
Q4 24
3.6%
23.1%
Q3 24
-2.0%
31.2%
Q2 24
-6.6%
26.4%
Q1 24
-17.9%
37.9%
Net Margin
BLFS
BLFS
CBFV
CBFV
Q4 25
58.9%
Q3 25
2.2%
-235.2%
Q2 25
-62.3%
29.3%
Q1 25
-1.9%
15.8%
Q4 24
82.5%
Q3 24
-8.0%
25.3%
Q2 24
-105.1%
21.8%
Q1 24
-55.4%
31.1%
EPS (diluted)
BLFS
BLFS
CBFV
CBFV
Q4 25
$0.23
$0.90
Q3 25
$0.01
$-1.07
Q2 25
$-0.33
$0.74
Q1 25
$-0.01
$0.35
Q4 24
$0.27
$0.45
Q3 24
$-0.04
$0.60
Q2 24
$-0.45
$0.51
Q1 24
$-0.22
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
CBFV
CBFV
Cash + ST InvestmentsLiquidity on hand
$33.0M
$31.7M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$371.9M
$157.5M
Total Assets
$405.9M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
CBFV
CBFV
Q4 25
$33.0M
$31.7M
Q3 25
$29.5M
$55.9M
Q2 25
$31.9M
$64.5M
Q1 25
$66.9M
$61.3M
Q4 24
$91.5M
$49.6M
Q3 24
$24.0M
$147.3M
Q2 24
$22.0M
$142.6M
Q1 24
$29.7M
$73.7M
Total Debt
BLFS
BLFS
CBFV
CBFV
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Q1 24
$24.3M
Stockholders' Equity
BLFS
BLFS
CBFV
CBFV
Q4 25
$371.9M
$157.5M
Q3 25
$353.7M
$152.5M
Q2 25
$347.2M
$148.4M
Q1 25
$352.6M
$148.3M
Q4 24
$348.9M
$147.4M
Q3 24
$325.5M
$149.1M
Q2 24
$321.4M
$142.9M
Q1 24
$333.4M
$141.6M
Total Assets
BLFS
BLFS
CBFV
CBFV
Q4 25
$405.9M
$1.5B
Q3 25
$392.1M
$1.5B
Q2 25
$387.2M
$1.5B
Q1 25
$395.1M
$1.5B
Q4 24
$399.5M
$1.5B
Q3 24
$381.7M
$1.6B
Q2 24
$375.0M
$1.6B
Q1 24
$401.6M
$1.5B
Debt / Equity
BLFS
BLFS
CBFV
CBFV
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.05×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
CBFV
CBFV
Operating Cash FlowLast quarter
$4.9M
$17.8M
Free Cash FlowOCF − Capex
$17.2M
FCF MarginFCF / Revenue
124.1%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
0.44×
TTM Free Cash FlowTrailing 4 quarters
$29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
CBFV
CBFV
Q4 25
$4.9M
$17.8M
Q3 25
$6.1M
$4.6M
Q2 25
$7.4M
$4.1M
Q1 25
$1.7M
$4.0M
Q4 24
$1.6M
$6.8M
Q3 24
$4.8M
$3.1M
Q2 24
$6.5M
$-1.2M
Q1 24
$-4.5M
$3.3M
Free Cash Flow
BLFS
BLFS
CBFV
CBFV
Q4 25
$17.2M
Q3 25
$4.5M
Q2 25
$3.9M
Q1 25
$3.9M
Q4 24
$3.4M
Q3 24
$2.2M
Q2 24
$-2.4M
Q1 24
$2.3M
FCF Margin
BLFS
BLFS
CBFV
CBFV
Q4 25
124.1%
Q3 25
186.5%
Q2 25
28.8%
Q1 25
32.5%
Q4 24
26.0%
Q3 24
17.4%
Q2 24
-19.6%
Q1 24
17.0%
Capex Intensity
BLFS
BLFS
CBFV
CBFV
Q4 25
4.7%
Q3 25
4.3%
Q2 25
1.9%
Q1 25
0.8%
Q4 24
25.1%
Q3 24
6.7%
Q2 24
10.0%
Q1 24
7.2%
Cash Conversion
BLFS
BLFS
CBFV
CBFV
Q4 25
0.44×
Q3 25
9.83×
Q2 25
1.05×
Q1 25
2.11×
Q4 24
0.13×
Q3 24
0.95×
Q2 24
-0.44×
Q1 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons